US 12053444
Therapeutic compounds, formulations, and uses thereof
granted A61KA61K31/18A61K47/10
Quick answer
US patent 12053444 (Therapeutic compounds, formulations, and uses thereof) held by Tvardi Therapeutics, Inc. expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Tvardi Therapeutics, Inc.
- Grant date
- Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/18, A61K47/10, A61K47/26, A61K47/44